SOUTH SAN FRANCISCO, Calif., & PARIS--(BUSINESS WIRE)--DNA Script, a world leader in Enzymatic DNA Synthesis (EDS) and DNA on demand, has been named to Fast Company’s prestigious annual list of the ...

SOUTH SAN FRANCISCO, Calif. & PARIS--(BUSINESS WIRE)--DNA Script, a pioneer in Enzymatic DNA Synthesis (EDS) and DNA printing on demand, today announced it has raised $165 million in a Series C ...

DNA Script was created to revolutionize DNA writing with enzymes. Their core research and development efforts have produced innovations in enzyme engineering, surface and nucleotide chemistries and ...

DNA Script announced a significant advancement in oligonucleotide synthesis technology, enabling the production of custom DNA sequences of up to 500 nucleotides in length with unprecedented sequence ...

Following the launch of its benchtop DNA printer earlier this year, DNA Script has secured a hefty $165 million to take its platform to the masses. The nine-digit proceeds represent a big leap in DNA ...

The SYNTAX System Delivers DNA On Demand to Enable Labs to Control Their Workflow, Innovate Faster SOUTH SAN FRANCISCO, Calif., and PARIS, May 20, 2021 /PRNewswire/ -- DNA Script, a leading pioneer in ...

SOUTH SAN FRANCISCO, Calif. and PARIS, June 15, 2021 /PRNewswire/ -- DNA Script, a pioneer in DNA printing on demand, today announced the commercial launch of their SYNTAX platform with their first ...

DNA Script SAS nabbed $165 million in a series C fundraising round to support commercialization of the company’s Syntax platform and expand its portfolio of products powered by enzymatic DNA synthesis ...